INHIBITION OF BONE EROSION, DETERMINED BY HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY (HR-PQCT), IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING A CONVENTIONAL SYNTHETIC DMARD (CSDMARD) PLUS DENOSUMAB VS CSDMARD THERAPY ALONE: RESULTS OF AN OPEN-LABEL, RANDOMIZED, PARALLEL-GROUP STUDY

N. Iwamoto,K. Chiba,S. Sato, K. Shiraishi,K. Watanabe, N. Ohki, A. Okada, T. Koga, M. Kobayashi, K. Saito, N. Okubo, A. Kawakami

ANNALS OF THE RHEUMATIC DISEASES（2022）

引用 0|浏览2

暂无评分

关键词

denosumab vs csdmard therapy,rheumatoid arthritis,bone erosion,rheumatoid arthritis patients,high-resolution,hr-pqct,open-label,parallel-group

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要